Zura Bio
ZURA
87 hedge funds and large institutions have $107M invested in Zura Bio in 2024 Q4 according to their latest regulatory filings, with 25 funds opening new positions, 32 increasing their positions, 10 reducing their positions, and 15 closing their positions.
220% more repeat investments, than reductions
Existing positions increased: 32 | Existing positions reduced: 10
79% more call options, than puts
Call options by funds: $522K | Put options by funds: $291K
67% more first-time investments, than exits
New positions opened: 25 | Existing positions closed: 15
12% more funds holding
Funds holding: 78 → 87 (+9)
7.31% more ownership
Funds ownership: 58.38% → 65.69% (+7.3%)
29% less capital invested
Capital invested by funds: $151M → $107M (-$43.9M)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JP Morgan Chase
New York
|
+$9.3M |
| 2 |
Millennium Management
New York
|
+$2.34M |
| 3 |
BlackRock
New York
|
+$1.22M |
| 4 |
Adage Capital Partners
Boston,
Massachusetts
|
+$1.07M |
| 5 |
CM
Caption Management
Oklahoma City,
Oklahoma
|
+$424K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACM
ADAR1 Capital Management
Austin,
Texas
|
-$6.03M |
| 2 |
SC
Stempoint Capital
New York
|
-$4.24M |
| 3 |
PAMP
Polar Asset Management Partners
Toronto,
Ontario, Canada
|
-$1.05M |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$994K |
| 5 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
-$333K |
ZURA Hedge Fund Activity: Q4 2024 in Review
87 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in Zura Bio (ZURA) for Q4 2024, worth a combined $107M — down 29% from $151M a quarter earlier.
Buyers outnumbered sellers: 25 funds opened new ZURA positions and 15 closed out — a net gain of 10 holders — while 32 added to existing stakes and 10 trimmed.
The largest buyer was JP Morgan Chase, adding an estimated $9.3M. The largest seller was ADAR1 Capital Management, cutting an estimated $6.03M.
- 87 institutional investors held Zura Bio (ZURA) as of Q4 2024, up from 78 in Q3 2024.
- Funds reported $107M of Zura Bio stock for Q4 2024, down 29% quarter-over-quarter.
- 25 funds opened new Zura Bio positions in Q4 2024 and 15 closed out, a net change of +10 holders.
- The largest Zura Bio buyer in Q4 2024 was JP Morgan Chase, an estimated $9.3M added.
- The largest Zura Bio seller in Q4 2024 was ADAR1 Capital Management, an estimated $6.03M sold.
Based on aggregated 13F filings for Q4 2024.